PMDA drug package insert
エナジア吸入用カプセル中用量
PMDA Prescription drug · ノバルティスファーマ株式会社 · package insert May 12, 2025
Key facts
| Brand names | エナジア吸入用カプセル中用量, エナジア吸入用カプセル高用量 |
|---|---|
| Nonproprietary names | インダカテロール酢酸塩・グリコピロニウム臭化物・モメタゾンフランカルボン酸エステル |
| Companies | 製造販売（輸入）／ノバルティスファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 3成分配合喘息治療剤 |
| Therapeutic category codes | 87229 |
| YJ codes | 2290807G1026, 2290807G2022 |
| Approval numbers | 30200AMX00492000, 30200AMX00493000 |
| Package insert edition | 第7版 |
| Package insert date | May 12, 2025 |
| PMDA document key | 300242_2290807G1026_1 |
| PMDA company code | 300242 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: